I. Overview of Clinical Trial Endpoints for Common Ophthalmic DiseasesThe appropriate selection of endpoints in ophthalmic drug clinical trials directly determines the scientific validity of a study a...
April 11 is World Parkinson’s Day. With over 10 million people affected worldwide and no cure yet, Investigator-Initiated Trials (IITs) offer the flexibility to test novel targets and mechanisms, pav...
IntroductionCell and Gene Therapy (CGT) is transforming the treatment landscape for difficult-to-treat diseases, particularly cancers and rare disorders. However, the path from lab to market remains s...
